ROCKET PHARMACEUTICALS, INC. (RCKT) › Operating Cash FlowROCKET PHARMACEUTICALS, INC. (RCKT) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2016: -$5.50M2017: -$15.96M2018: -$53.79M2019: -$64.66M2020: -$74.64M2021: -$121.16M2022: -$178.14M2023: -$194.92M2024: -$209.72M2025: -$190.01M-$190.01M2016Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$190.01M+9.4%2024-$209.72M-7.6%2023-$194.92M-9.4%2022-$178.14M-47.0%2021-$121.16M-62.3%2020-$74.64M-15.4%2019-$64.66M-20.2%2018-$53.79M-237.0%2017-$15.96M-190.1%2016-$5.50M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share